Treatment of myofascial pain syndrome: comparison of physiologic saline interfascial injection and lidocaine trigger point injectio

Phase 3

Completed

• Conditions: Myofascial pain syndrome with trigger point at upper trapezius muscle; Myofascial pain syndrome; Trigger point

• Registration Number: TCTR20190926003
• Lead Sponsor: HRH Princess Chulabhorn College of Medical Science

Brief Summary

Physiologic saline interfascial and lidocaine trigger point injections effectively decreased MPS pain in the upper trapezius muscle at 2 and 4 weeks after treatment. However, lidocaine trigger point injection demonstrated better pain improvement at 10 minutes after treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-09-26
• Study Completion: 2020-04-24
• Results First Posted: 2021-03-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

1.Diagnosis of myofascial pain syndrome in upper trapezius muscle based on Travell and Simon criteria by physiatrist
2.Having at least 1 active trigger point on upper trapezius muscle
3.No history of physical therapy or injection for
myofascial pain syndrome within the past 3 months
4.No history of pain killer medication within past 48 hours
5.Able to communicate in thai language

Exclusion Criteria

1.Bleeding tendency
2.History of neck and shoulder trauma
3.Other neck and shoulder pain condition eg. fibromyalgia, cervical radiculopathy, adhesive capsulitis
4.Allergy to lidocaine

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain visual analogue scale baseline, 10 minutes, 2 weeks and 4 weeks after intervention Asking patient to point straight horizontal 100 mm line to define pain score

Secondary Outcome Measures

Name	Time	Method
eck ROM baseline, 10 minutes, 2 weeks and 4 weeks after intervention Measure neck flexion, extension, rotation, lateral bending by goniometer